You have no items in your shopping cart.
Search results for: 'CD3'
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 10.6&12.8 KDa. Observed: 16-30 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 28.5 KDa. Observed: 32-40 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.7 KDa. Observed: 40-50 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 10.4 KDa. Observed: 20-35 KDa, reducing conditions
500 μg, 1 mg, 10 μg, 50 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38 KDa. Observed: 38-55 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 36.7 KDa. Observed: 50-65 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 14.6&16.0 KDa. Observed: 20&(22-38) KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μgFC, WB
Human, Mouse
Monoclonal
Unconjugated
0.1 mg



